Y-Intercept (HK)’s Cytokinetics CYTK Stock Holding History

Y-Intercept (HK)’s Portfolio CYTK Stock Details CYTK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	–	Sell	-43,619	Closed	-$3.72M	–	1675
2026 Q2	$3.72M	Buy	+43,619	New	+$3.13M	0.07%	384
2026 Q1	–	Sell	-5,790	Closed	-$368K	–	1647
2025 Q4	$368K	Sell	5,790 -18,942	-77%	-$1.18M	0.01%	1319
2025 Q3	$1.36M	Buy	+24,732	New	+$1.02M	0.03%	823
2024 Q1	–	Sell	-33,215	Closed	-$2.77M	–	1438
2023 Q4	$2.77M	Buy	+33,215	New	+$1.2M	0.26%	78
2022 Q3	–	Sell	-12,270	Closed	-$482K	–	1025
2022 Q2	$482K	Buy	+12,270	New	+$494K	0.06%	439

Other funds holding CYTK

Polaris Capital Management Boston, Massachusetts $953M AUM 27.74% 1-Year Est. Return

E. Ohman J:or Asset Management Stockholm, Sweden $4.47B AUM 27.58% 1-Year Est. Return

Pinnacle Associates New York $8.92B AUM 43.91% 1-Year Est. Return

Mirador Capital Partners Pleasanton, California $859M AUM 41.74% 1-Year Est. Return

Mutual of America Capital Management New York $10.1B AUM 33.74% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return

Amalgamated Bank New York $14.3B AUM 35.81% 1-Year Est. Return

Louisiana State Employees Retirement System Baton Rouge, Louisiana $6.56B AUM 41.43% 1-Year Est. Return

Yousif Capital Management Bloomfield Hills, Michigan $8.87B AUM 34.1% 1-Year Est. Return

Tema ETFs New York $2.69B AUM 42.96% 1-Year Est. Return

Y-Intercept (HK)'s CYTK Position: Q3 2026 in Review

Y-Intercept (HK) sold out of Cytokinetics (CYTK) in Q3 2026, closing a stake of 43,619 shares — an estimated $3.72M sold.

Y-Intercept (HK) first reported a position in CYTK in Q2 2022 and held it in 5 quarters. The position peaked at $3.72M in Q2 2026. 60 funds tracked by Wall St. Rank hold CYTK as of Q3 2026.

Y-Intercept (HK) reported no remaining Cytokinetics position as of Q3 2026 after selling out during the quarter.
Y-Intercept (HK) sold 43,619 Cytokinetics shares in Q3 2026, an estimated $3.72M.
Y-Intercept (HK) first reported a position in Cytokinetics in Q2 2022 and held it in 5 quarters.
Y-Intercept (HK)'s Cytokinetics position peaked at $3.72M in Q2 2026.
60 funds tracked by Wall St. Rank held Cytokinetics as of Q3 2026.

Based on Y-Intercept (HK)'s 13F filing for Q3 2026, filed 16 Oct 2026.